icatibant accord
accord healthcare s.l.u. - icatibant acetate - angioedema, paveldima - other hematological agents - icatibant accord is indicated for symptomatic treatment of acute attacks of hereditary angioedema (hae) in adults, adolescents and children aged 2 years and older, with c1 esterase inhibitor deficiency.
icatibant fresenius
fresenius kabi polska sp.z.o.o. - ikatibantas - injekcinis tirpalas užpildytame švirkšte - 30 mg - icatibant
icatibant teva
teva b.v. - ikatibantas - injekcinis tirpalas užpildytame švirkšte - 30 mg - icatibant
firazyr
takeda pharmaceuticals international ag - icatibantas - angioedema, paveldima - Širdies terapija - firazyr skirtas simptominiam ūmiosios angioedemos (hae) išemijos suaugusiems pacientams gydyti (su c1 esterazės inhibitoriaus trūkumu).